Parkinson's disease (PD), caused by selective loss of dopaminergic (DA) neurons in the substantia nigra, is the most common movement disorder with no cure or effective treatment. Exposure to the mitochondrial complex I inhibitor rotenone recapitulates pathological hallmarks of PD in rodents and selective loss of DA neurons in Drosophila. However, mechanisms underlying rotenone toxicity are not completely resolved. We previously reported a neuroprotective effect of human uncoupling protein 2 (hUCP2) against rotenone toxicity in adult fly DA neurons. In the current study, we show that increased mitochondrial fusion is protective from rotenone toxicity whereas increased fission sensitizes the neurons to rotenone-induced cell loss in vivo. In primary DA neurons, rotenone-induced mitochondrial fragmentation and lethality is attenuated as the result of hucp2 expression. To test the idea that the neuroprotective mechanism of hUCP2 involves modulation of mitochondrial dynamics, we detect preserved mitochondrial network, mobility and fusion events in hucp2 expressing DA neurons exposed to rotenone. hucp2 expression also increases intracellular cAMP levels. Thus, we hypothesize that cAMP-dependent protein kinase (PKA) might be an effector that mediates hUCP2-associated neuroprotection against rotenone. Indeed, PKA inhibitors block preserved mitochondrial integrity, movement and cell survival in hucp2 expressing DA neurons exposed to rotenone. Taken together, we present strong evidence identifying a hUCP2-PKA axis that controls mitochondrial dynamics and survival in DA neurons exposed to rotenone implicating a novel therapeutic strategy in modifying the progression of PD pathogenesis.
Introduction
Epidemiological studies suggested pesticide exposure as a risk factor for the sporadic form of Parkinson's disease (PD), which constitutes over 90% of all PD cases (Banerjee et al., 2009; Liou et al., 1997; Sanders and Timothy Greenamyre, 2013) . In a rodent PD model, intraperitoneal injection of the mitochondrial complex I inhibitor rotenone, found in common pesticides resulted in PD-like motor defects, loss of dopaminergic (DA) neurons and α-synuclein and poly-ubiquitin positive aggregates in DA neurons (Cannon et al., 2009) , notwithstanding previous controversial findings under similar treatment conditions Hoglinger et al., 2003; Zhu et al., 2004) . In Drosophila, long-term exposure to rotenone leads to selective DA neurodegeneration and the loss of climbing ability that is alleviated by L-DOPA ingestion (Coulom and Birman, 2004) . As rotenone induces key PD features in both vertebrate and invertebrate model systems, its toxicity is generally thought to involve mitochondrial dysfunction and oxidative stress (Hisahara and Shimohama, 2010) . Consistent with its role as a mitochondrial complex I inhibitor, rotenone exerts its neurotoxicity through oxidative stress (Panov et al., 2005; Sherer et al., 2003a) and energy depletion (Yadava and Nicholls, 2007) . Seemingly not connected to the disruption of mitochondrial respiration: microtubule disruption (Choi et al., 2011) and microglial activation (Gao et al., 2002) are also attributable to rotenone toxicity. Controversy remains as to whether complex I inhibition is required for rotenone toxicity in DA neurons (Choi et al., 2008; Marella et al., 2008) .
Mitochondrial fusion and fission are dynamic processes that regulate the morphology, distribution, function and turnover of those organelles (Twig et al., 2008) . Mutations in mitofusin 2 (Mfn2) and optic atrophy 1 (Opa1), two proteins driving mitochondrial outer and inner membrane fusion are associated with the neurodegenerative diseases CharcotMarie-Tooth type 2A and dominant optic atrophy, respectively (Alexander et al., 2000; Delettre et al., 2000) . Similarly, perturbation in mitochondrial fission protein dynamin-related protein 1 (Drp1) in hippocampal neurons reduces dendritic spine growth and synaptic plasticity (Li et al., 2004) . Mitochondrial fission mediates 1-methyl-4-phenylpyridinium (MPP+) toxicity (Wang et al., 2011) whereas exposure to rotenone results in mitochondrial fragmentation, autophagic turnover of mitochondria and cell death (Barsoum et al., 2006; Chu et al., 2013) . Drp1 is intimately associated with the apoptotic process (Arnoult, 2007) in which Drp1-mediated mitochondrial fragmentation augments the release of cytochrome C from mitochondria, an early step in apoptosis (Cassidy-Stone et al., 2008) . As a major regulator of Drp1 activity, cAMP-dependent protein kinase (PKA) phosphorylates Drp1 and leads to its cytosolic sequestration promoting an elongated mitochondrial network (Cereghetti et al., 2008; Chang and Blackstone, 2007; Cribbs and Strack, 2007) . A neuroprotective role of PKA phosphorylation of Drp1 has been suggested as constitutive Drp1 phosphorylation at the consensus PKA site inhibits cytochrome C release and apoptosis in neuronal PC12 cells (Cribbs and Strack, 2007) . Furthermore, PKA targeted to mitochondria through the scaffold protein A kinase anchoring protein 1 (AKAP1) exerts neuroprotection against PINK1 deficiency in a cellular PD model by phosphorylating Drp1 and blunting its fission activity Merrill et al., 2011) . These findings suggest that PKA exerts its protective effect by controlling mitochondrial shape and subsequent function through attenuation of mitochondrial fission. While excess mitochondrial fission increases reactive oxygen species (ROS), disrupts calcium homeostasis, impairs mitochondrial respiratory capacities and facilitates many forms of apoptosis (Chan, 2006) , the influence of mitochondrial dynamics on toxininduced DA neurodegeneration in vivo has not been reported.
Neuronal uncoupling proteins (UCP2, UCP4 and UCP5) promote survival in the CNS (Andrews et al., 2005a) . In the brain, UCPs are thought to exert a cytoprotective effect through dissipation of the proton gradient generated during substrate oxidation. This results in decreased protonmotive force leading to a reduced mitochondrial ROS production while maintaining long-term ATP homeostasis (Andrews et al., 2005a; Azzu et al., 2010) . Consistent with its expression in the substantia nigra, UCP2 activity is involved in maintaining nigrostriatal DA neuronal function (Andrews et al., 2005b) . Interestingly, although reduced oxidative stress is associated with its protective effect in cell models, UCP2 activity in catecholaminergic neurons protects MPP+-induced DA neuron loss but not toxin associated oxidative damage (Conti et al., 2005) . Thus, additional mechanisms are likely involved in UCP2-mediated DA neuroprotection.
We previously reported that targeted hucp2 expression under the control of the tyrosine hydroxylase (TH) promoter has a neuroprotective effect against rotenone-induced DA neuron loss (Islam et al., 2012) . To examine the hUCP2 protective mechanism, we developed primary DA neuronal cultures from midgastrula embryos and recapitulated the hUCP2 protective effect against rotenone in vitro. Furthermore, we demonstrated that increased expression of the mitochondrial fission molecule Drp1 sensitized brain DA neurons to rotenone toxicity and overexpression of mitochondrial fusion molecules Marf (Drosophila homologue for Mfn) or Opa1 protected those neurons from rotenone toxicity. Rotenone-induced mitochondrial fragmentation was detected in primary DA neurons, so we investigated whether the protective effect of hUCP2 involved mitochondrial remodeling. In genetic interaction studies, we detected a rough eye phenotype only when hucp2 is coexpressed with Marf or Opa1 whereas no such additive effect was observed as the result of co-expression of hucp2 and drp1, suggesting functional cooperation between hUCP2 and mitochondrial fusion pathways. Consistent with the genetic interaction study, we found preserved mitochondrial morphology, mobility, and fusion events in hucp2 expressing but not control primary DA neurons exposed to rotenone. In brain DA neurons, heightened sensitivity to rotenone toxicity from drp1 overexpression was rescued by the expression of hucp2, further indicating a role of hUCP2 in countering mitochondrial fission. Based on these results, we hypothesized that, when cells are stressed with rotenone treatment, hUCP2 activity modulates mitochondrial bioenergetics to trigger cAMP-dependent PKA activity leading to decreased mitochondrial fission and increased cell survival. In support of this idea, we detected elevated cAMP levels in Drosophila S2R + cells harboring hUCP2 activity. Also, elongated mitochondria and increased mitochondrial mobility were measured in primary neurons exposed to forskolin, a PKA activator. Consistent with our hypothesis, we show that preserved mitochondrial length, mobility, fusion events, and survival in hucp2 expressing neurons exposed to rotenone were abrogated in the presence of two independent PKA inhibitors. Our results point to a hUCP2-PKA axis in preserving mitochondrial integrity and mobility as well as enhancing cell survival to counter rotenone toxicity.
Results
The mitochondrial fusion/fission machinery modifies rotenone-induced brain DA neuron loss Blocking mitochondrial fission attenuates rotenone-induced apoptosis in primary cortical neurons (Barsoum et al., 2006) . However, the impact of mitochondrial fusion/fission regulation on rotenone toxicity in vivo has not been described. To begin our investigation into the cellular mechanism underlying the protective effect of hUCP2 against rotenone in brain DA neurons, we asked whether rotenone toxicity could be modulated by mitochondrial dynamics in vivo. To address this question, we used the well-established UAS/Gal4 expression system to increase the expression of mitochondrial fusion or fission molecules in brain DA neurons with the THNGFP driver where co-expression of GFP in the same neurons allowed the quantification of rotenoneinduced cell loss (Islam et al., 2012; Park et al., 2007) . Several UAS lines previously shown to overexpress mitochondrial fission molecule Drp1, its dominant negative version (Drp1 K38A ) as well as mitochondrial fusion proteins Marf or Opa1 were employed in our study (Park et al., 2009) . We independently verified the overexpression status of each target gene in the heads of these flies after crossing to the THNGFP driver (Supplemental Fig. 1 ). To assess rotenone-induced neurodegeneration, we quantified the number of DA neurons in the protocerebral posterior 1 (PPL1) cluster in each brain hemisphere (Ng et al., 2012) . As shown in Fig. 1 , there was a 29% loss in DA neurons in control flies as the result of rotenone exposure. Interestingly, drp1 expression sensitized DA neurons to rotenone toxicity, causing a 58% loss of those neurons. In contrast, promoting mitochondrial fusion with the expression of Marf or Opa1 protected DA neurons from rotenone toxicity ( Fig. 1B ; PPL1 neuron numbers: control 11.1 ± 0.22; control + rot 7.9 ± 0.49; Drp1 10 ± 0.39; Drp1 + rot 4.2 ± 0.74; Marf 10.1 ± 0.53; Marf + rot 9.7 ± 0.9; Opa1 10.6 ± 0.65; Opa1 + rot 11 ± 1, N = 15-20). Furthermore, blocking mitochondrial fission with the dominant negative form of Drp1, Drp1
K38A also rendered DA neurons more resistant to rotenone toxicity (data not shown). Taken together, these results demonstrate that the mitochondrial fusion/fission machinery plays an important role in modulating rotenone toxicity in DA neurons, with mitochondrial fusion being protective and mitochondrial fission exacerbating rotenone toxicity.
hucp2 expression protects against rotenone-induced mitochondrial fragmentation and lethality in primary DA neurons
We recently reported that a significant protection against rotenoneinduced brain DA neuron loss is achieved in THNhUCP2 flies (Islam et al., 2012) . Based on our in vivo findings that increased mitochondrial fission exacerbated rotenone toxicity, we reasoned that mitochondrial integrity might be better preserved in hucp2 expressing DA neurons exposed to rotenone. To test this idea, we established primary Drosophila DA neuronal cultures from midgastrula embryos to characterize in detail mitochondrial dynamics. We show that rotenone elicited dosedependent lethality of primary DA neurons ( Fig. 2A ) and this lethality was attenuated with hucp2 expression, where a 30% increase in survival was measured as compared to control neurons, recapitulating hUCP2 neuroprotective effect in vivo (Fig. 2B) (Islam et al., 2012) . To determine whether hUCP2 has a pro-survival activity, we also quantified TH + neurons in control and hucp2 expressing neurons under similar culturing conditions with the exception of rotenone exposure. As shown in Fig. 2C , similar TH + neuron numbers were counted in control or hucp2 expressing neurons suggesting the hUCP2 neuroprotective effect against rotenone lethality is not the result of a better survival in hucp2 expressing neurons.
While rotenone was shown to induce mitochondrial impairment in cultured cortical neurons (Barsoum et al., 2006) and neuroblastoma cells (Sherer et al., 2003b) , its effect on mitochondrial integrity in primary DA neurons has not been characterized. To monitor mitochondrial morphology, we measured mitochondrial length in primary DA neurons isolated from THNmitoGFP embryos in which mitochondria were GFPlabeled (Yang et al., 2008) . Following rotenone treatment, mitochondrial length was quantified in neuritic projections. As shown in Fig. 3 , rotenone exposure resulted in mitochondrial fragmentation where the average length of mitochondria in neuritic projections was shortened by 18%. While only a non-significant, small increase in the average mitochondrial length was detected in hucp2 expressing neurons as compared to controls, hucp2 expressing neurons were more resistant to rotenone induced mitochondrial fragmentation where the average mitochondrial length measured in these neurons exposed to rotenone was similar to that measured in control neurons ( Fig. 3E ; mitochondrial length: control 1.71 μm ± 0.06; control + rot 1.40 μm ± 0.03; hUCP2 1.81 μm ±0.1; hUCP2 + rot 1.93 μm ±0.1, N = 32-40). These results not only demonstrate rotenone-induced mitochondrial fragmentation in primary DA neurons but also show that hUCP2 is protective against rotenone in maintaining mitochondrial integrity.
Genetic interaction study indicates functional cooperation between hUCP2 and mitochondrial fusion molecules Our studies in primary neuronal cultures demonstrated that mitochondria are more elongated in hucp2 expressing neurons as compared to control neurons when exposed to rotenone. To explore the idea that hUCP2 activity might be involved in regulating mitochondrial dynamics, Fig. 1 . The mitochondrial fusion/fission machinery modifies rotenone toxicity in brain DA neurons. (A) Representative images of the GFP + DA neurons of the PPL1 cluster from whole mount adult brains following rotenone (Rot) treatment at 500 μM for 4 days. Scale bar = 10 μm. (B) Quantification of GFP + DA neurons of the PPL1 cluster demonstrates that increased expression of mitochondrial fission molecule exacerbates rotenone toxicity whereas increased expression of mitochondrial fusion molecules is protective. Scoring of the DA neurons was carried out in a "blind" fashion as previously described (Islam et al., 2012) . Each bar represents average ± S.E.M. P values were calculated by Student's t test. N = 15-20 brains/condition. Cont: THNUAS-GFP, w 1118 ; Drp1: THNUAS-GFP, UAS-drp1; Marf: THNUAS-GFP, UAS-Marf; and Opa1: THNUAS-GFP, UAS-Opa1. Fig. 2 . Rotenone-induced primary DA neuron loss is attenuated as the result of hucp2 expression. (A) Rotenone induces DA neuron death. Following rotenone exposure (0.1-1 μM) for 6 days, the number of TH+ neurons was normalized to 1000 DAPI+ cells and counted, showing a dose-dependent cell death as the result of rotenone exposure (Cont: 2.9 ± 0.51; 0.1 μM Rot: 2.55 ± 0.46; 0.5 μM Rot: 2.02 ± 0.26; 1 μM Rot: 1.7 ± 0.28). Each bar represents average ± S.E.M. N = 27-53 images from 3 neuronal preparations. (B) hucp2 expressing neurons are protected from rotenone toxicity. Increased survival of hucp2 expressing DA neurons as compared to control neurons was measured as percentage of neurons remaining following rotenone treatment/untreated neurons with the same genotype. Each bar represents average ± S.E.M. N = 72-79 images from 3 neuronal preparations. (C) hUCP2 activity does not promote cell survival. Comparable numbers of control or hucp2 expressing DA neurons were measured at 9 DIV (Cont: 2.9 ± 0.5; hUCP2: 3.0 ± 0.3). Each bar represents average ± S.E.M. N = 27-65 images from 3 neuronal preparations. P values were calculated by Student's t test. In these experiments, total numbers of DAPI + cells were determined at 9 DIV as follows: Cont: 808.59 ± 37.62 and hUCP2: 800.31 ± 37.53 indicating similar culturing conditions. Cont: THNUAS-GFP, w
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; hUCP2: THNUAS-GFP, UAS-hucp2.
we performed a genetic interaction study using the eye-specific GMRGal4 driver to reveal any phenotypic changes in the Drosophila compound eye as the result of co-expression of hucp2 and mitochondrial fission or fusion molecules. Similar genetic epistatic analyses corroborated a role of PINK1 in promoting mitochondrial fission (Poole et al., 2008) and a functional relationship between Rhomboid-7, PINK1, Parkin and the PD-linked mitochondrial serine protease Omi . As shown in Fig. 4 , expression of hucp2, drp1, Marf or Opa1 alone in the Drosophila eye rendered no discernible phenotype from that of a control eye (Panels A-E). Interestingly, a rough eye phenotype was detected when hucp2 and Marf are co-expressed (compare Panels C&G) or when hucp2 and Opa1 were co-expressed (compare Panels D&H). In contrast, no such additive phenotypic effect was detected when hucp2 and drp1 were co-expressed (compare Panels B&F). To further corroborate those results, we used an RNAi approach to render a pro-fusion environment by down-regulating drp1 and a pro-fission environment by down-regulating Marf or Opa1, or via overexpression of parkin or PINK1 (Park et al., 2009; Poole et al., 2008; Ziviani et al., 2010) . Down-regulation of target genes in THNDrp1RNAi, THNMarfRNAi and THNOpa1RNAi flies were verified (Supplemental Fig. 1 ). As shown in Supplemental Fig. 2 , co-expression of hucp2 and Drp1RNAi again resulted in a rough eye phenotype whereas no such additive effect was observed when hucp2 and MarfRNAi or hucp2 and Opa1RNAi were coexpressed. Finally, co-expression of hucp2 and fission promoting molecules parkin or PINK1 resulted in no additive eye phenotype. As these results strongly suggest functional cooperation between hUCP2 and mitochondrial fusion pathways, we predicted similar mitochondrial morphology in DA neurons expressing hucp2 or fusion molecules. To test this possibility, we co-expressed mitoGFP with hucp2, Marf, Opa1 or drp1 using the THNmitoGFP driver and captured mitochondrial morphology in brain DA neurons. Similar to the morphological changes reported previously (Park et al., 2009; Yang et al., 2008) , we detected dispersed mitochondria in a tubular-like network in control or drp1 expressing brain DA neurons (Supplemental Figs. 3A and M) . Distinctive morphological alterations were observed upon expression of fusion molecules Marf or Opa1 resulting in more fused, aggregate mitochondria (Supplemental Figs. 3D and G). As predicted, when targeting hUCP2 to TH+ neurons, mitochondrial morphology observed in these neurons closely resembled that as the result of Marf or Opa1 expression (Supplemental Fig. 3J ). While it is surprising that drp1 overexpression does not result in obvious mitochondrial fragmentation, it is possible that brain DA neurons are more sensitive to mitochondrial aggregation as shown in Marf or Opa1 expressing neurons. Thus, in the absence of increased expression of fusion proteins, mitochondria remain more dispersed, tubular shaped even under overexpression of a fission protein.
Nevertheless, these results suggest a role of hUCP2 in regulating mitochondrial morphology towards mitochondrial fusion.
hUCP2 activity rescues heightened rotenone sensitivity in drp1 expressing brain DA neurons
The analysis of mitochondrial morphology in DA neurons suggested an involvement of hUCP2 in promoting more fused mitochondria. This notion is consistent with the results showing more elongated mitochondria in hucp2 expressing neurons than in control neurons exposed to rotenone (Fig. 3) . To further test the hypothesis that hUCP2 promotes mitochondrial fusion or inhibits fission, we asked whether hUCP2 activity would rescue the heightened rotenone sensitivity in DA neurodegeneration as the result of drp1 expression. Consistent with the results shown in Fig. 1 , drp1 expression rendered brain DA neurons more sensitive to rotenone induced cell death as revealed by immunostaining of whole mount brains with an anti-TH antibody (Fig. 5) . Furthermore, this effect was reversed as the result of hucp2 expression ( Fig. 5E ; PPL1 neuron numbers: control 10.8 ± 0.25; control + rot 8.31 ± 0.43; Drp1 + rot 7.2 ± 0.32; hUCP2, Drp1 + rot 9.7 ± 0.13; N = 16-21). These results suggest that hUCP2 activity counters increased sensitivity to rotenone-induced DA cell loss as the result of drp1 overexpression.
Mitochondrial fusion events are preserved in DA neurons exposed to rotenone as the result of hucp2 expression Under rotenone treatment, more elongated mitochondria measured in hucp2 expressing neurons than in control neurons suggested increased mitochondrial fusion or decreased fission. To distinguish between those two possibilities, we determined whether mitochondrial fusion would be affected by hUCP2 activity in primary neurons exposed to rotenone. We generated transgenic flies harboring a mitochondrially localized photo-convertible fluorescent protein, MitoDendra2 (Wang et al., 2008) and measured mitochondrial fusion events in primary DA neurons co-expressing MitoDendra2 and hucp2. Following photoconversion, we counted the proportion of photo-converted mitochondria undergoing fusion over time in primary DA neurons as previously described where mitochondrial fusion events are defined as diffusion of red MitoDendra2 fluorescence as one photo-converted mitochondrion fused to a non-converted one (Berman et al., 2009) . As shown in Fig. 6 , we detected a large, 72% reduction in the proportion of mitochondria undergoing fusion events in control neurons treated with rotenone. In contrast, diminished mitochondrial fusion events induced by rotenone treatment were restored in hucp2 expressing neurons under the same treatment condition ( Fig. 6B ; % photo-converted mitochondrial undergoing fusion events: control 40.3 ± 2.1; control + rot 11.1 ± 3.2; hUCP2 + rot 48.3 ± 9.6; N = 74-84). These results clearly demonstrate that rotenone-induced defects in mitochondrial fusion are ameliorated as the result of hucp2 expression.
PKA activity is required for maintaining mitochondrial dynamics and integrity in hucp2 expressing neurons exposed to rotenone Our results show that promoting mitochondrial fusion through expression of fusion molecules is protective from rotenone's toxic effects on DA neuron loss. Consistently, we show that hucp2 expressing DA neurons maintain elongated mitochondria, mitochondrial fusion events and are more resistant to rotenone-induced cell death as compared to controls. To determine the underlying mechanisms affecting mitochondrial dynamics in hucp2 expressing neurons, we considered bioenergetic consequences as the result of increased mitochondrial uncoupling. UCP uncouples substrate oxidation from ATP phosphorylation resulting in a decrease of intracellular ATP and an increase of both cAMP and AMP levels (Galluzzi et al., 2011) . Activation of cAMPdependent PKA was recently shown to promote elongated mitochondria under starvation conditions through phosphorylation of Drp1 thereby preventing its translocation to mitochondria and execution of 
and drp1 in the eye renders a similar, normal phenotype as seen when expressing each molecule alone (B, E). A rough eye phenotype is observed when co-expressing hucp2 and Marf (G) or hucp2 and Opa1 (H). GMR: GMR-Gal4. Magnification = 100×. ; Drp1: THNUAS-drp1; hUCP2, Drp1: THNUAS-drp1, UAS-hucp2. its fission activity (Gomes et al., 2011) . To establish a mechanistic link of hUCP2 and PKA activation, we asked if cytosolic cAMP levels could be influenced by increased hUCP2 activity. To assess cellular cAMP levels as the result of hucp2 expression, we adopted Drosophila S2R + cells to manipulate hUCP2 activity under the control of the copper inducible metallothionein promoter (Barkus et al., 2008) . As shown in Supplemental Fig. 4A , copper inducible expression of the hUCP2-GFP fusion protein was detected in mitochondria of S2R+ cells. We next assessed cAMP levels in the presence of the hUCP2-GFP fusion protein and measured a 67% increase in cytosolic cAMP levels in those cells as compared to GFP expressing cells under copper induction (Supplemental Fig. 4B ). To demonstrate that the hUCP2-GFP fusion protein was fully functional, we show that rotenone-induced membrane depolarization was largely restored in S2R+ cells harboring the hUCP2-GFP fusion protein under rotenone exposure (Supplemental Fig. 4C ). These results provide critical evidence placing PKA as a potential effector downstream of hUCP2 activity.
Next, we investigated whether PKA activation would regulate mitochondrial morphology and cell survival under rotenone treatment conditions. Forskolin, an activator of adenylyl cyclase, stimulates PKA activity by increasing intracellular cAMP levels , was used to elicit PKA activation in primary DA neurons. As shown in Fig. 7 , primary DA neurons pretreated with forskolin were significantly protected from rotenone induced mitochondrial fragmentation ( Fig. 7E ; mitochondrial length: control 1.71 μm ± 0.06; control + FSK 2.12 μm ± 0.09; control + rot 1.4 μm ± 0.03; control + FSK + rot 2.33 μm ± 0.12, N = 31-42). Likewise, rotenone-induced cell death was significantly reduced as the result of forskolin pretreatment (Fig. 7  F; number of TH + neurons/1000 cells: control: 4.1 ± 0.1; control + rot: 1.9 ± 0.2; control + FSK + rot: 3.6 ± 0.3, N = 72-79). These results demonstrate that a PKA activator preserves mitochondrial integrity and survival to counter rotenone toxicity in DA neurons. To further determine whether mitochondrial length maintained in forskolin treated neurons exposed to rotenone is associated with increased mitochondrial fusion, we measured fusion events under these conditions. As shown in Fig. 8A , pretreatment with forskolin substantially restored mitochondrial fusion events attenuated by rotenone treatment. Interestingly, pre-treatment of hucp2 expressing neurons with H89, a PKA inhibitor (Gomes et al., 2011) significantly blocked the protective effect on mitochondrial fusion events when exposed to rotenone by 56% ( Fig. 8A ; % mitochondrial fusion events: control 40.3 ± 2.1; control + rot 11.1 ± 3.2; control + FSK + rot 49 ± 7.9; hUCP2 + rot 48.3 ± 9.6 hUCP2 + H89 + rot 21.7 ± 3.8; N = 75-84). Finally, corroborating the findings that intact PKA activity is needed for maintaining mitochondrial fusion activity in hucp2 expressing neurons exposed to rotenone, we measured the effect of two independent PKA inhibitors, H89 and Rp-8-Br-cAMPS (Lochner and Moolman, 2006) on mitochondrial length in hucp2 expressing neurons exposed to rotenone. We found that mitochondrial length in hucp2 expressing neurons exposed to rotenone was significantly shortened in the presence of H89 or Rp-8-BrcAMPS, similar to that observed in control neurons treated with rotenone ( Fig. 8F ; mitochondrial length: control + rot 1.3 μm ± 0.04; hUCP2 + rot 1.86 μm ± 0.12; hUCP2 + rot + H89 1.26 μm ± 0.06; hUCP2 + rot + Rp-8-Br-cAMPS 1.41 μm ±0.04; control + H89 1.33 μm ± 0.05; control + Rp-8-Br-cAMPS 1.54 μm ± 0.07; N = 31-42). Taken together, these results indicate that mitochondrial fusion events and elongated mitochondria maintained in hucp2 expressing neurons exposed to rotenone require intact PKA activity.
Mitochondrial mobility is necessary for fusion events. To monitor the effect of rotenone on mitochondrial movement, we generated kymographs through time-lapse imaging of GFP labeled mitochondria in neurites of primary DA neuron culture (Pham et al., 2012) . We found that control mitochondria are rather mobile as displayed by diffused, diagonal tracks along the vertical time axis (Fig. 9A) . In sharp contrast, straight tracks showing little mitochondrial movement were recorded in control neurons exposed to rotenone with a 26% decrease in mitochondrial mobility (Figs. 9A&C, % mitochondrial mobility: control 37 ± 3; control + FSK 57 ± 5.3; control + rot 11 ± 1.8; control + FSK + rot 39 ± 4.3; hUCP2 53.5 ± 4.7; hUCP2 + rot 45.4 ± 4.7; hUCP2 + rot + H89 4.3 ± 1.4; hUCP2 + rot + Rp-8-BrcAMPS 12.3 ± 1.3; N = 11-30). Interestingly, forskolin treatment promoted mitochondrial mobility by 19% and effectively attenuated rotenone-induced movement defects (Figs. 9B,D&I) . To assess how hUCP2 impacts on mitochondrial mobility, we measured a 15% increase in mobility as the result of hucp2 expression when compared to controls (Figs. 9E&I) . Consistent with its rescuing effect on rotenone-induced mitochondrial fragmentation and impaired fusion events, hucp2 expressing neurons were resistant to rotenone-induced mitochondrial immobility (Figs. 9F&I) . Finally, confirming our findings that the hUCP2-PKA pathway promotes mitochondrial integrity to counter rotenone toxicity, kymograph recordings showed that mitochondrial mobility maintained in hucp2 expressing neurons exposed to rotenone was blocked in the presence of H89 or Rp-8-Br-cAMPS (Figs. 9F-I ). Additional kymograph recordings demonstrating the effect of PKA Mitochondria labeled with photo-convertible MitoDendra2 (Wang et al., 2008) were recorded for mitochondria fusion events in neurites of primary DA neurons pretreated with 500 nM rotenone for 8 h at 4 DIV. Before photo-conversion (Pre), mitoDendra2 emits green fluorescence. At time 0, selected mitochondria (marked in squares) were exposed to laser at 405 nm for photo-conversion from green to red fluorescence. Following photo-conversion, time-lapse recordings of mitochondrial fusion events were collected for 30 min. Note extended time-lapse images shown for mitochondria of control neurons treated with rotenone to illustrate lack of mitochondrial fusion events. Scale bar = 5 μm. (B) The proportion of photo-converted mitochondria under each treatment condition observed to undergo fusion within 30 min (see Material and methods). Mitochondrial fusion events are defined as diffusion of red fluorescence as one converted mitochondrion fused to a non-converted one (Karbowski et al., 2004) . Each bar represents average ± SEM. P values were calculated by Student's t test. N = 3-4 neuron preparations with a total of 74-84 mitochondria selected. Cont: THNw
, UAS-mitoDendra2; hUCP2: THNUAS-hucp2, UAS-mitoDendra2. inhibitors under control conditions or the specificity of the inhibitors in blocking forskolin effect are shown in Supplemental Fig. 5 . Taken together, our results strongly suggest a role of the hUCP2-PKA pathway in controlling mitochondrial mobility, fusion events and integrity to counter rotenone toxicity.
hUCP2 neuroprotective effect against rotenone requires PKA
Extending the findings that PKA activity is required to maintain mitochondrial morphology and dynamics in hucp2 expressing neurons exposed to rotenone, we examined whether PKA also functioned as an effector to mediate increased survival in hucp2 expressing neurons exposed to rotenone. To this end, we pretreated hucp2 expressing neurons with H89 before exposing those neurons to rotenone followed by measurements of annexin V binding to phosphatidylserine at the cell surface indicative of apoptotic death (Vermes et al., 1995) . Consistent with the results shown in Fig. 2 , hucp2 expressing neurons had less annexin V staining following rotenone treatment as compared to control neurons under the same treatment. Importantly, rotenone-induced apoptosis . Mitochondrial fusion in hucp2 expressing neurons exposed to rotenone requires intact PKA activity. (A) Quantification of mitochondrial fusion following photo-conversion of mitochondrially localized mitoDendra2 in neurites of primary DA neurons. Following pretreatment with the PKA activator forskolin (FSK) or inhibitor H89 for 1 h, neurons were exposed to rotenone for 8 h before photo-conversion of selected mitochondria and recording of photo-converted mitochondria under each treatment condition undergoing fusion within 30 min. Each bar represents average ± SEM. P values were calculated by Student's t test. N = 3-4 neuron preparations with a total of 74-85 mitochondria selected. Note the same controls (±Rot) and hUCP2 + Rot described in Fig. 6B were included in (A) as they were from the same experimental sets for relevant comparison. (B-F) Mitochondrial length maintained in hucp2 expressing primary DA neurons exposed to rotenone requires PKA activity. (B-E) Representative images of mitochondrial morphology in neuritic projections of control neurons treated with rotenone (Cont + Rot) (B), hucp2 expressing neurons treated with rotenone (hUCP2 + Rot) (C), hucp2 expressing neurons treated with H89 and rotenone (hUCP2 + H89 + Rot) (D) or hucp2 expressing neurons treated with Rp-8-Br-cAMPs and rotenone (hUCP2 + Rp-8-Br-cAMPS + Rot) (E) at 4 DIV. Scale bar = 5 μm. (F) Quantification of mitochondrial length under conditions B-E and in control neurons treated with PKA inhibitors. The Image J tool (NIH) was used to quantify the average mitochondrial length (see Materials and methods). Each bar represents average ± S.E.M. P values were calculated by Student's t test. **P b 0.01 and ***P b 0.001 when compared to controls. N = 3 experiments with a total of 31-42 images quantified. Rotenone (Rot): 500 nM for 8 h. FSK + Rot: FSK (20 μM) for 1 h followed by rotenone exposure; H89 + Rot: H89 (10 μM) for 1 h followed by rotenone exposure; Rp-8-BrcAMPS + Rot: Rp-8-Br-cAMPS (500 μM) for 1 h followed by rotenone exposure. Control: THNw
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, UAS-mitoGFP; hUCP2: THNUAS-hucp2, UAS-mitoGFP. attenuated in hucp2 expressing neurons was abrogated with H89 pretreatment ( Fig. 10E ; % apoptosis; control: 9.4 ± 0.02; control + rot: 24.2 ± 0.02; hucp2 + rot: 14.5 ± 0.03; hucp2 + H89 + rot: 50 ± 0.1, N = 26-33). It is noteworthy that rotenone exposure rendered higher apoptotic death in hucp2 expressing neurons pretreated with H89 as compared to control neurons treated with rotenone. We ruled out a potential toxic effect of H89 as control neurons pretreated with H89 had similar apoptotic events with (Fig. 10) or without rotenone treatment (data not shown). Taken together, these results strongly suggest that PKA activity is required in preserving cell survival in hucp2 expressing neurons exposed to rotenone.
Discussion
The rotenone model reproduces PD associated pathology in rodents, most notably Lewy body-like structure not achieved by either 6-hydroxydopamine or MPTP administration (Perier et al., 2003) . In Drosophila, rotenone induced motor impairment is alleviated by L-DOPA ingestion (Coulom and Birman, 2004) . Given its utility in modeling sporadic PD, a complete understanding of rotenone toxic action will likely have a significant impact on novel neuroprotective strategies. We previously reported that hucp2 expression in DA neurons protects those neurons from rotenone-induced cell death in Drosophila (Islam et al., 2012 ). In the current study, we demonstrate that modulation of mitochondrial dynamics has a profound influence in rotenone-induced DA neurodegeneration in vivo and characterize a novel hUCP2-PKA pathway in counteracting rotenone toxicity by maintaining mitochondrial integrity and mobility associated with enhanced cell survival. Fig. 9 . Kymograph recordings illustrate that mitochondrial mobility blocked by rotenone exposure is restored as the result of hUCP2 or PKA activity. Kymograph recordings illustrate abundant mitochondrial movements in a control neurite (A) that are blunted following rotenone exposure at 4 DIV (C). Treatment of forskolin (FSK) induces a significant increase in mitochondria mobility (B) and rescues rotenone-induced movement defects (D). Similar to FSK treatment, hucp2 expression promotes mitochondria mobility (E) resulting in heightened resistance to rotenone-induced movement defects (F) that requires PKA activity (G&H). Each representative image shows movements of GFP labeled mitochondria recorded during 10 min of time-lapse imaging. The initial frame of each live-imaging series is displayed above the kymograph generated from the movie. The xaxis represents mitochondrial position. Over y-axis, diffused, diagonal tracks represent movement of mitochondria and straight tracks represent stationary mitochondria. (I) Percentage of mobile mitochondria quantified over a 10-min imaging period under each condition. Each bar represents average ± S.E.M. P values were calculated by Student's t test. N = 3 experiments with a total of 11-30 images quantified. Scale bar = 5 μm. Rotenone (Rot): 500 nM for 8 h. Forskolin (FSK): 20 μM for 8 h. FSK + Rot: FSK (20 μM) for 1 h followed by rotenone exposure. H89 + Rot: H89 (10 μM) for 1 h followed by rotenone exposure. Rp-8-Br-cAMPS + Rot: Rp-8-Br-cAMPS (500 μM) for 1 h followed by rotenone exposure. Control: THNw
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, UAS-mitoGFP; hUCP2: THNUAS-hucp2, UAS-mitoGFP. We show that in brain DA neurons, increased drp1 expression sensitizes those neurons to rotenone-induced cell loss whereas increased expression of Marf or Opa1 engenders a protective effect. Using various live-cell imaging techniques, we extensively characterized rotenone toxicity on mitochondrial dynamics and morphology. In primary DA neuron cultures treated with rotenone, we measured stagnant mitochondrial movement, decreased mitochondrial fusion events and shortened mitochondrial length. Consistent with the current understanding that efficient mitochondrial fusion process allows complementary equilibration of matrix metabolites, intact mtDNA copies and mitochondrial membrane constituents (Reviewed in Twig and Shirihai (2011) ) whereas tipping mitochondrial dynamics towards fission advances cell death (Frank et al., 2001; Yu et al., 2005) , our in vivo and in vitro DA neuron studies have substantiated a direct role of mitochondrial dynamics in modulating rotenone neurotoxicity. Recently, it was shown that lacking mitochondrial fusion molecule Mfn2 in a subset of DA neurons in mice results in mitochondrial fragmentation and also severely diminishes transport of the organelle leading to progressive nigrostriatal neurodegeneration (Pham et al., 2012) . As growing evidence has pointed to an important role of Mfn2 in mitochondrial transport (Misko et al., 2010) , our findings of decreased mitochondrial mobility as the result of rotenone exposure in primary DA neurons implicate that impaired mitochondrial transport and subsequent energy deficiency in neuronal terminals may be involved in rotenone neurotoxicity in vivo. Contrary to our findings of stagnant mitochondrial movement following shortterm rotenone exposure, chronic rotenone treatment of primary cortical neurons leads to increased retrograde mitochondrial transport (Arnold et al., 2011) . This discrepancy in mitochondrial movement in response to rotenone between the two models is likely due to compensatory mitochondrial homeostatic responses such as biogenesis not accounted for in our model with acute rotenone exposure (Arnold et al., 2011) . As several neurotoxins including nitric oxide, MPP + and rotenone induce mitochondrial fission followed by cell death in vitro, future in vivo models could assess whether promoting mitochondrial fusion and transport is a useful approach to counter toxin-induced DA neurodegeneration.
Based on the findings that the mitochondrial fusion/fission machinery modifies rotenone toxicity, we were prompted to ask whether the hUCP2 neuroprotective effect against rotenone involved mitochondrial remodeling. Indeed, under rotenone treatment, we show that mitochondrial morphology and dynamics as well as cell survival are better preserved in hucp2 expressing neurons as compared to control neurons. Consistent with our genetic interaction studies indicating functional cooperation between hUCP2 and the mitochondrial fusion pathway, we detected more fused mitochondrial morphology in brain DA neurons expressing hucp2 similar to that observed as the result of overexpression of mitochondrial fusion molecule Marf or Opa1. These observations are strongly corroborated by our in vitro findings, where hUCP2 activity is associated with preserved mitochondrial fusion activity in neurons exposed to rotenone. Consistent with a higher number of mitochondrial fusion events recorded in hucp2 expressing neurons versus controls exposed to rotenone, mitochondria are more elongated in these neurons. This increased fusion activity is presumably facilitated by a betterpreserved mitochondrial mobility. As a result, elongated mitochondria are more resistant to rotenone toxicity through maintaining a mitochondrial network for efficient repair of damaged mitochondria (Twig and Shirihai, 2011) . Indeed, we show in Drosophila S2R + cells that hUCP2 activity renders those cells more resistant to rotenone-induced mitochondrial depolarization, a strong indication of mitochondrial health.
In an effort to elucidate the underlying mechanism whereby hUCP2 influences mitochondrial dynamics, we explored bioenergetic consequences of increased mitochondrial uncoupling and identified cAMPdependent PKA as the novel downstream effector in restoring mitochondrial dynamics as well as cell survival in countering rotenone toxicity. These findings are significant as they explain at least in part, the hUCP2 neuroprotective mechanism. Furthermore, to our knowledge, we have provided the first evidence of a protective role for PKA against rotenone in primary DA neurons. We show that rotenone associated defects in mitochondrial morphology and mobility are significantly restored in the presence of a PKA activator, forskolin. Consistent with its uncoupling activity, increased hUCP2 activity results in higher cAMP levels in our S2R+ system, providing a plausible mechanism of PKA activation. In line with our hUCP2-PKA model, we show that preserved mitochondrial length, fusion events and movement in hucp2 expressing primary neurons exposed to rotenone require intact PKA activity.
Among several modes of post-translational modification in regulating Drp1 function, reversible phosphorylation at Ser PKA by PKA serves to inhibit mitochondrial fission (Chang and Blackstone, 2007; Cribbs and Strack, 2007) . During starvation and a concomitant rise of intracellular cAMP levels, activation of PKA is shown to promote elongated mitochondria to escape autophagy (Gomes et al., 2011) . In a cellular PD model, PKA targeted to mitochondria ameliorates mitochondrial defects as the result of PINK1 deficiency, and these protective effects are mimicked by constitutive phosphorylation of Drp1 at Ser PKA . To understand the mechanism whereby PKA affected Drp1 function, it was elegantly shown that Drp1 phosphorylation by PKA inhibits the disassembly step of its catalytic cycle leading to accumulation of large, non-functional Drp1 oligomers at the outer mitochondrial membrane (Merrill et al., 2011) . In these reports, steady-state elongated mitochondrial morphology was measured as the result of PKA activation or mitochondrial localization of PKA, which is associated with cell survival against pro-apoptotic insults. In our study, we quantified mitochondrial fusion events and determined that rotenone-induced impairment of mitochondrial fusion is significantly reversed in the presence of forskolin. While our results suggest a possible role of PKA in influencing mitochondrial fusion, additional study is required to fully investigate whether PKA is involved in the mitochondrial fusion process.
In the presence of a PKA inhibitor, mitochondrial integrity, preserved mitochondrial fusion events and mobility as well as enhanced survival in hucp2 expressing primary DA neurons exposed to rotenone are abrogated. These results provide strong evidence for a novel UCP2-PKA axis in neuroprotection against toxin rotenone. However, we did not detect a significant change in mitochondrial length or increased mitochondrial fusion in hucp2 expressing neurons under basal conditions. It is conceivable that without external stress, mitochondrial morphology and dynamics are maintained by a homeostatic equilibrium of fusion and fission events. In the presence of rotenone however, when mitochondrial dynamics is shifted towards fission, UCP2-PKA activity mediated mitochondrial fusion is effective in maintaining mitochondrial integrity and cell survival. While our findings do not rule out additional protective mechanisms such as decreased oxidative stress as the result of hucp2 expression, they provide a novel link between UCP2 activity and preserved mitochondrial integrity through activation of PKA in countering DA neuron toxin rotenone. Drosophila models of rare familial forms of PD provided profound insights into the physiological roles of PINK1 and Parkin in mitochondrial remodeling and quality control (Greene et al., 2003; Poole et al., 2008; Yang et al., 2008) . Comparatively few advances have been made in utilizing this genetic system to identify novel protective mechanisms against toxin-related degeneration of DA neurons. We show that in our in vivo and in vitro toxin models promoting elongated mitochondria counters rotenone mediated DA neurodegeneration. Moreover, we demonstrate a novel hUCP2-PKA protective mechanism in DA neurons against rotenone-induced mitochondrial fission and cell death thus highlighting the importance of balanced mitochondrial dynamics in DA neuron health. As increasing evidence identifies inducible transcriptional regulation of neuronal ucp expression, it is conceivable to develop therapeutic strategies for PD by targeting UCP2 (reviewed in Ho et al. (2012) ).
Materials and methods

Generation and maintenance of fly lines
The TH-Gal4 driver line was obtained from the Bloomington Stock Center (Friggi-Grelin et al., 2003) . The homozygous UAS-hucp2 fly line was previously shown to render neuroprotection in THNhUCP2 flies exposed to rotenone (Islam et al., 2012) . The homozygous, double transgenic UAS-hucp2; TH-Gal4 fly line was generated via genetic crosses followed by genomic PCR and qPCR analysis to confirm hucp2 expression in fly heads. The THNGFP line was a gift from Dr. S. Birman (Dev. Biol. Institute of Marseille, France) and THNmitoGFP flies were provided by Dr. B. Lu (Stanford University). The UAS-Drp1, UASDrp1 K38A , UAS-Marf, UAS-Opa1, UAS-Parkin and UAS-PINK1 fly lines were kind gifts of Dr. J. Chung (Seoul National University, Korea). The UAS-mitoDendra2 construct was generated based on a CMVmitoDendra2 construct (Wang et al., 2008) . Following germ-line transformation, several homozygous UAS-mitoDendra2 lines were generated and tested for expression. Homozygous, double transgenic THNmitoDendra2 fly lines were generated via genetic crosses followed by imaging analysis of DA-specific expression of mitoDendra2. UASDrp1RNAi (Stock# 27682), UAS-MarfRNAi (Stock# 31157) and UASOpa1RNAi (Stock# 32358) lines were obtained from the Bloomington Stock Center. GMRNhUCP2 double transgenic flies were generated by meiotic recombination. All fly stocks were maintained in a humidified, temperature-controlled incubator with 12 h on/off light cycle at 25°C on standard corn meal/yeast/sucrose/agar diet.
Chemicals
Rotenone, forskolin, H89 and Rp-8-Br-cAMPS were purchased from Sigma (St. Louis, MO).
Isolation and culturing of primary DA neurons
Midgastrula embryos were collected and dechorionated in 50% bleach solution. The embryonic contents were harvested and plated on FluoroDish glass bottom dishes precoated with poly-D-lysine (World Precision Instruments Inc., Sarasota, FL) as previously described (Park and Lee, 2006; Park et al., 2007) . Primary neuron cultures were incubated under 5% CO 2 at 25°C and maintained for up to 9 days in vitro (DIV). Culture medium (DDM1) used in this study was a mixture of high glucose Ham's F-12/Dulbecco's medium (Irvine Scientific, Santa Ana, CA), L-glutamine (2.5 mM; Irvine Scientific), HEPES (20 mM; Irvine Scientific), and 4 supplements: 100 μM putrescine, 20 ng/ml progesterone, 100 μg/ml transferrin, and 50 μg/ml insulin (Calbiochem, San Diego, CA).
Immunofluorescent staining and quantification of TH+ primary neurons
Cell survival in control or hucp2 expressing neurons was measured at 9 DIV. To measure rotenone-induced cell death, rotenone dissolved in DMSO was added to cultures at 3 DIV for 6 days before quantification of DA neurons. Primary neurons were fixed with 4% paraformaldehyde for 40 min on ice. The cultures were washed 3 times with 10 mM phosphate buffer solution (PBS). Blocking and permeabilization steps were done by using 0.1% Triton X-100 and 5% goat serum (Sigma, St. Louis, MO) for 30 min on ice. The permeablized cultures were incubated with a primary anti-TH antibody (ImmunoStar Inc., WI) overnight at 4°C and then with a TRITC labeled secondary antibody (Jackson ImmunoResearch Laboratories Inc., PA) for 1 h at 25°C. After staining was completed the cultures were washed 3 times for 10 min, then the coverslips were mounted on glass slides and viewed under a fluorescent microscope (Olympus IX71). Images were taken with a Spot CCD digital camera (Diagnostic Instruments, Sterling Heights, MI). To count total cells in each image, DAPI (Molecular Probes, OR) was used as previously described (Park and Lee, 2006) . In order to minimize the subjectivity in manual cell counting, we used Image J software (http://rsb.info.nih.gov/ ij/index.html). A sample area in each image was chosen to calculate the unit pixel intensity (UPI) for each cell. The UPI was obtained by dividing the pixel intensity in a sample area with the manually counted number of cells in that area (typically 30-60 cells). Then the total DAPI signal intensity in an image was measured and divided by the UPI in order to quantify the total number of DAPI + cells in that image. Finally, the number of TH + DA neurons in that image was normalized to 1000 DAPI+ cells. A total of 72-79 images from three independent neuronal preparations were counted.
Immunofluorescent staining and quantification of TH+ neurons in adult brains
Ten-day-old flies were starved on 1% agar containing vials for 6 h before subjected to rotenone treatment in vials containing 1% agar mixed with 5% sucrose and 500 μM rotenone for four-five days. Whole-mount immunofluorescent staining of adult brains was performed essentially as described (Islam et al., 2012) . Briefly, following fixation in 4% paraformaldehyde, adult brains were dissected and permeabilized with 1% Triton/PBS, blocked with 5% normal goat serum and immunoprobed with an anti-TH antibody (ImmunoStar Inc., WI) at 4°C for two days followed by incubation with a secondary antibody conjugated with TRITC (Jackson ImmunoResearch Laboratories Inc., PA) for two hours at 25°C. Following three washes in triton-containing PBS, the immunostained brains were mounted on cover slips for confocal microscopy. Z-series images with a 0.2 μm step size were captured with 60 × oil objective and TH+ DA neurons were quantified with a "blind" method as described previously (Fridell et al., 2009) . Essentially, each experiment involved two people where one person performed the staining and the other read the slides, which have been numerically "blinded" by the first person.
Confocal imaging and quantification of mitochondrial morphology
To measure mitochondrial length, THNmitoGFP harboring primary DA neurons were seeded onto poly-D-lysine-coated FluoroDish glass bottom dishes as described above. All imaging experiments were performed at 4 DIV in a well-equipped live-imaging chamber (Pathology Devices LiveCell™) attached to the confocal stage with controlled 5% CO 2 content, humidity and constant temperature at 25°C. A series of projected z-section images was collected using Nikon A1R confocal microscope (Nikon, Inc.) equipped with a 60 × immersion oil objective lens with additional digital zoom of 2×. Images were digitally processed using Nikon NIS Element software. Otsu's method was used to generate thresholded binary images. To measure mitochondrial length, the particle analysis plugin in Image J was used and the length of the major axis was used to define mitochondrial length. Due to variations in mitochondrial size within each field imaged, mitochondrial length in each condition was determined by measuring the mean mitochondrial length in each field of view and at least 30 individual fields were analyzed for each condition.
To analyze mitochondrial mobility, THNmitoGFP neurons were recorded using time-lapse imaging. Images were acquired every 10 s for 10 min under confocal microscopy with pinhole set at 2 airy units and at minimum laser intensity to minimize laser-induced cellular damage. Kymographs were created using Image J/Multiple Kymograph software (NIH). Mitochondrial mobility was visualized by movement tracks displayed in kymographs. Each track represents one mitochondrion. Vertical tracks represent stationary mitochondria whereas diffused, diagonal tracks indicate movements of mitochondria (Deng et al., 2013) . Mitochondrial mobility was quantified by counting the percentage of mitochondria that moved over a 10 min imaging period. A mitochondrion was considered stationary if it remained immobile for the entire recording period. Mitochondrion is labeled as a motile one if its displacement was ≥5 μm.
Quantification of mitochondrial fusion events
Following photo-conversion, quantification of mitochondrial fusion events was performed as described previously with slight modification (Berman et al., 2009 ). Imaging of THNmitoDendra2 harboring primary neurons was performed using a Nikon A1R confocal microscope with a live imaging station as described above. For imaging, fields containing neuritic projection expressing MitoDendra2 were identified, and 3 to 6 mitochondria per field were randomly selected for photo-conversion. The selected mitochondria were photo-converted from green to red fluorescence by exposing highly zoomed area to 405-nm laser at 4% intensity for 5 iterations. Time-lapse imaging was initiated immediately after photo-conversion and frames were captured every 30 s for 30 min (60 images) with excitation at 488 and 560 nm. For all studies, 3-4 fields per dish and 2 replicate dishes per condition were evaluated in each of four independent experiments. Mitochondrial fusion events were quantified based on the diffusion of red fluorescence from one converted mitochondrion to another green, non-converted one, by a manual review of captured images with treatment conditions blinded to the analyzer. The proportion of mitochondrial fusion events was determined by counting the number of photo-converted MitoDendra2-labeled mitochondria undergoing fusion in a total population of the randomly selected photo-converted mitochondria in all the selected fields over the 30 min imaging period.
Apoptosis assays
THNGFP or THNGFP, hUCP2 harboring primary neurons grown on FluoroDish glass bottom dishes were exposed to rotenone (500 nM) at 4 DIV for 24 h. To measure the effect of H89 on rotenone-induced apoptosis, neurons were pretreated with H89 for 1 h at 10 μM. Following rotenone or H89 + rotenone treatment, GFP+ DA neurons were washed two times with 1× Annexin V binding buffer, which was supplied with the apoptosis detection kit (Biotium Inc., Hayward, CA) and then stained with diluted Annexin V-CF™594 conjugated in 1 × binding buffer to a final concentration of 0.25 μg/ml at 25°C for 30 min. After staining was completed, the neurons were washed once with 1× binding buffer and imaged immediately. A z-series of optical sections with a 0.5 μm step size was recorded using a confocal microscope (Nikon A1R). Red fluorescence of Annexin V stained phosphatidylserine (PS) on the cell surface indicates apoptotic cells. For all studies, 15 fields per dish per condition were evaluated in each of the three independent experiments. The proportions of GFP+ DA neurons with Annexin V staining were quantified.
S2R+ studies
Inducible pMT/hUCP2-GFP and pMT/GFP constructs were generated with the pMT-puro expression plasmid (Addgene). The resulting constructs were verified by sequencing and stably transfected into S2R+ cells using standard procedures. Following Cu 2+ induction (250 μM for 24 h), mitochondrial localization of hUCP2-GFP was determined by immunofluorescent staining with an anti-GFP antibody (Santa Cruz, CA) and mitotracker red (Life Technologies, NY). Cells were imaged using confocal microscopy (Nikon A1R) with a 60 × oil objective lens plus 3× digital amplification. Intracellular cAMP levels were measured in pMT/GFP or pMT/ hUCP2-GFP harboring S2R+ cells using the Cyclic AMP XP Assay Kit according to manufacturer's procedure (Cell Signaling Technology, MA). Briefly, cells grown in a 12-well plate (~1 × 10 6 /well) were induced with Cu 2+ at 250 μM for 24 h prior to cell lysis and competitive enzyme-linked immunoassay (EIA). Triplicate samples were measured in each experiment with a total of four experiments performed.
Real-time analysis of ΔΨm in pMT/GFP or pMT/hUCP2-GFP harboring cells was performed using the membrane sensor TMRE at 20 nM (Molecular Probes, OR). Following Cu 2+ induction, rotenone (50 nM) or vehicle (DMSO) was added to cells. Cells were immediately imaged every minute for 20 min with confocal microscopy using a 60 × oil objective lens plus 1.5× digital amplification (Nikon A1R). Changes in TMRE fluorescence intensity were analyzed using the Image J software (NIH). Three independent experiments were performed.
Quantitative real-time RT-PCR expression analysis
Total RNA was isolated from heads of 10-day-old females raised on standard diet using the TRIzol method, and subsequent cDNA and real-time RT-PCR experiments were performed as described previously (Fridell et al., 2009) . Two-three separate RNA preparations with triplicates in each QPCR experiment were used to derive the mean ratios of target gene expression against the reference genes GAPDH or Tubulin with primers described previously (Fridell et al., 2009; Neretti et al., 2009) . The following primers with catalog numbers from SABiosciences were used: Drp1 (PPD02066A-200), Marf (PPD00513A-200), and Opa1 (PPD04655A-200).
